GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Traws Pharma, Inc. (TRAW) | 8/14/2026 5:00:40 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Assets $11,470,000 | EPS -$0.16 | ||
| Traws Pharma, Inc. (TRAW) | 8/14/2026 4:40:18 PM | View | Financials | Earnings | SEC | 2Q 2026 | Assets $11,470,000 | EPS -$0.16 | Export Earnings Model | ||
| Traws Pharma, Inc. (TRAW) | 5/29/2026 9:01:49 AM | View | Proxy | SEC | Y 2025 | ||||||
| Traws Pharma, Inc. (TRAW) | 5/15/2026 7:26:16 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Assets $8,156,000 | EPS -$0.53 | ||
| Traws Pharma, Inc. (TRAW) | 5/15/2026 7:06:12 AM | View | Financials | Earnings | SEC | 1Q 2026 | Assets $8,156,000 | EPS -$0.53 | Export Earnings Model | ||
| Traws Pharma, Inc. (TRAW) | 4/30/2026 4:51:15 PM | Micro | View | Financials | 10-K/A | SEC | Y 2025 ending: 12/31/2025 | Rev: $2,790,000 +1,134.5% | Assets $10,617,000 | EPS $0.82 | |
| Traws Pharma, Inc. (TRAW) | 4/15/2026 4:55:29 PM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $2,790,000 +1,134.5% | Assets $10,617,000 | EPS $0.82 | |
| Traws Pharma, Inc. (TRAW) | 4/15/2026 4:04:57 PM | View | Financials | Earnings | SEC | 1Q 2026 | Assets $8,156,000 | EPS -$0.53 | Export Earnings Model | ||
| Traws Pharma, Inc. (TRAW) | 11/13/2025 7:46:42 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Assets $12,443,000 | EPS -$0.34 | ||
| Traws Pharma, Inc. (TRAW) | 11/13/2025 7:01:48 AM | View | Financials | Earnings | SEC | 3Q 2025 | Assets $12,443,000 | EPS -$0.34 | Export Earnings Model | ||
| Traws Pharma, Inc. (TRAW) | 10/8/2025 4:17:15 PM | View | Proxy | SEC | Y 2024 | ||||||
| Traws Pharma, Inc. (TRAW) | 8/14/2025 7:12:58 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Rev: $2,733,000 +4,694.7% | Assets $15,622,000 | EPS -$0.11 | |
| Traws Pharma, Inc. (TRAW) | 8/14/2025 7:02:40 AM | View | Financials | Earnings | SEC | 2Q 2025 | Rev $2,733,000 +4,694.7% | Assets $15,622,000 | EPS -$0.11 | Export Earnings Model | |
| Traws Pharma, Inc. (TRAW) | 5/15/2025 4:13:25 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Rev: $57,000 +1.8% | Assets $19,063,000 | EPS $2.09 | |
| Traws Pharma, Inc. (TRAW) | 5/15/2025 7:01:02 AM | View | Financials | Earnings | SEC | 1Q 2025 | Rev $57,000 +1.8% | Assets $19,063,000 | EPS $2.09 | Export Earnings Model | |
| Traws Pharma, Inc. (TRAW) | 4/30/2025 4:44:41 PM | Micro | View | Financials | 10-K/A | SEC | Y 2024 ending: 12/31/2024 | Rev: $226,000 0.0% | Assets $24,962,000 | EPS -$35.21 | |
| Traws Pharma, Inc. (TRAW) | 3/31/2025 4:43:02 PM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $226,000 0.0% | Assets $24,962,000 | EPS -$35.21 | |
| Traws Pharma, Inc. (TRAW) | 3/31/2025 9:22:53 AM | View | Financials | Earnings | SEC | Y 2024 | Rev $56,000 0.0% | Assets $24,962,000 | EPS $95.66 | Export Earnings Model | |
| Traws Pharma, Inc. (TRAW) | 2/6/2025 4:18:53 PM | View | Proxy | SEC | Y 2024 | ||||||
| Traws Pharma, Inc. (TRAW) | 11/14/2024 5:21:56 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Rev: $57,000 0.0% | Assets $8,936,000 | EPS -$8.81 | |
| Traws Pharma, Inc. (TRAW) | 11/14/2024 4:41:12 PM | View | Financials | Earnings | SEC | 3Q 2024 | Rev $57,000 0.0% | Assets $8,936,000 | EPS -$8.81 | Export Earnings Model | |
| Traws Pharma, Inc. (TRAW) | 10/11/2024 8:47:48 AM | View | Proxy | SEC | Y 2023 | ||||||
| Traws Pharma, Inc. (TRAW) | 8/15/2024 7:31:13 AM | View | Financials | Earnings | SEC | 2Q 2024 | Rev $57,000 0.0% | Assets $18,686,000 | EPS -$4.87 | Export Earnings Model | |
| Traws Pharma, Inc. (TRAW) | 8/15/2024 6:17:59 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $57,000 0.0% | Assets $18,686,000 | EPS -$4.87 | |
| Traws Pharma, Inc. (TRAW) | 8/9/2024 6:06:04 AM | View | Proxy | SEC | Y 2023 | ||||||
| Traws Pharma, Inc. (TRAW) | 5/16/2024 4:20:12 PM | View | Financials | Earnings | SEC | 1Q 2024 | Rev $56,000 0.0% | Assets $18,172,000 | EPS -$0.24 | Export Earnings Model | |
| Traws Pharma, Inc. (TRAW) | 5/15/2024 5:39:32 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $56,000 0.0% | Assets $18,172,000 | EPS -$0.24 | |
| Traws Pharma, Inc. (TRAW) | 4/29/2024 4:18:42 PM | Micro | View | Financials | 10-K/A | SEC | Y 2023 ending: 12/31/2023 | Rev: $226,000 0.0% | Assets $22,683,000 | EPS -$0.90 | |
| Onconova Therapeutics, Inc. (TRAW) | 4/1/2024 4:21:00 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $226,000 0.0% | Assets $22,683,000 | EPS -$0.90 | |
| Onconova Therapeutics, Inc. (TRAW) | 11/15/2023 6:02:44 AM | View | Financials | Earnings | SEC | 3Q 2023 | Rev $57,000 0.0% | Assets $27,038,000 | EPS -$0.23 | Export Earnings Model | |
| Onconova Therapeutics, Inc. (TRAW) | 11/14/2023 8:47:34 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $57,000 0.0% | Assets $27,038,000 | EPS -$0.23 | |
| Onconova Therapeutics, Inc. (TRAW) | 8/14/2023 5:37:44 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Rev: $57,000 0.0% | Assets $30,468,000 | EPS -$0.20 | |
| Onconova Therapeutics, Inc. (TRAW) | 8/10/2023 5:20:00 PM | View | Financials | Earnings | SEC | 2Q 2023 | Rev $57,000 0.0% | Assets $30,468,000 | EPS -$0.20 | Export Earnings Model | |
| Onconova Therapeutics, Inc. (TRAW) | 6/7/2023 4:31:55 PM | View | Proxy | SEC | Y 2022 | ||||||
| Onconova Therapeutics, Inc. (TRAW) | 5/15/2023 5:31:15 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Rev: $56,000 0.0% | Assets $35,061,000 | EPS -$0.28 | |
| Onconova Therapeutics, Inc. (TRAW) | 5/15/2023 5:21:40 PM | View | Financials | Earnings | SEC | 1Q 2023 | Rev $56,000 0.0% | Assets $35,061,000 | EPS -$0.28 | Export Earnings Model | |
| Onconova Therapeutics, Inc. (TRAW) | 5/1/2023 4:42:28 PM | Micro | View | Financials | 10-K/A | SEC | Y 2022 ending: 12/31/2022 | Rev: $226,000 0.0% | Assets $39,372,000 | EPS -$0.91 | |
| Onconova Therapeutics, Inc. (TRAW) | 3/30/2023 5:02:25 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $226,000 0.0% | Assets $39,372,000 | EPS -$0.91 | |
| Onconova Therapeutics, Inc. (TRAW) | 3/16/2023 5:03:09 PM | View | Financials | Earnings | SEC | Y 2022 | Rev $56,000 0.0% | Assets $39,372,000 | EPS -$0.26 | Export Earnings Model | |
| Onconova Therapeutics, Inc. (TRAW) | 11/14/2022 4:59:01 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Rev: $57,000 0.0% | Assets $43,780,000 | EPS -$0.26 | |
| Onconova Therapeutics, Inc. (TRAW) | 11/14/2022 4:26:31 PM | View | Financials | Earnings | SEC | 3Q 2022 | Rev $57,000 0.0% | Assets $43,780,000 | EPS -$0.26 | Export Earnings Model | |
| Onconova Therapeutics, Inc. (TRAW) | 8/15/2022 6:20:24 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Rev: $57,000 0.0% | Assets $48,074,000 | EPS -$0.19 | |
| Onconova Therapeutics, Inc. (TRAW) | 8/11/2022 5:27:02 PM | View | Financials | Earnings | SEC | 2Q 2022 | Rev $57,000 0.0% | Assets $48,074,000 | EPS -$0.19 | Export Earnings Model | |
| Onconova Therapeutics, Inc. (TRAW) | 5/25/2022 5:21:19 PM | View | Proxy | SEC | Y 2021 | ||||||
| Onconova Therapeutics, Inc. (TRAW) | 5/13/2022 4:31:07 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Rev: $56,000 0.0% | Assets $51,422,000 | EPS -$0.20 | |
| Onconova Therapeutics, Inc. (TRAW) | 5/11/2022 4:09:11 PM | View | Financials | Earnings | SEC | 1Q 2022 | Rev $56,000 0.0% | Assets $51,422,000 | EPS -$0.20 | Export Earnings Model | |
| Onconova Therapeutics, Inc. (TRAW) | 4/29/2022 5:19:50 PM | Micro | View | Financials | 10-K/A | SEC | Y 2021 ending: 12/31/2021 | Rev: $226,000 -2.2% | Assets $55,478,000 | EPS -$0.96 | |
| Onconova Therapeutics, Inc. (TRAW) | 3/21/2022 5:21:01 PM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Rev: $226,000 -2.2% | Assets $55,478,000 | EPS -$0.96 | |
| Onconova Therapeutics, Inc. (TRAW) | 3/17/2022 4:07:55 PM | View | Financials | Earnings | SEC | Y 2021 | Rev $56,000 -1.8% | Assets $55,478,000 | EPS -$0.16 | Export Earnings Model | |
| Onconova Therapeutics, Inc. (TRAW) | 11/15/2021 5:44:15 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Rev: $57,000 -13.6% | Assets $59,990,000 | EPS -$0.22 | |
| Onconova Therapeutics, Inc. (TRAW) | 11/12/2021 6:07:22 AM | View | Financials | Earnings | SEC | 3Q 2021 | Rev $57,000 -13.6% | Assets $59,990,000 | EPS -$0.22 | Export Earnings Model | |
| Onconova Therapeutics, Inc. (TRAW) | 8/16/2021 4:51:48 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Rev: $57,000 +1.8% | Assets $44,378,000 | EPS -$0.27 | |
| Onconova Therapeutics, Inc. (TRAW) | 8/12/2021 4:18:35 PM | View | Financials | Earnings | SEC | 2Q 2021 | Rev $57,000 +1.8% | Assets $44,378,000 | EPS -$0.27 | Export Earnings Model | |
| Onconova Therapeutics, Inc. (TRAW) | 5/28/2021 5:19:00 PM | View | Proxy | SEC | Y 2020 | ||||||
| Onconova Therapeutics, Inc. (TRAW) | 5/17/2021 5:52:08 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Rev: $56,000 +7.7% | Assets $48,849,000 | EPS -$0.32 | |
| Onconova Therapeutics, Inc. (TRAW) | 5/17/2021 4:19:14 PM | View | Earnings | SEC | 1Q 2021 | Rev $56,000 +7.7% | Assets $48,849,000 | EPS -$0.32 | |||
| Onconova Therapeutics, Inc. (TRAW) | 3/18/2021 5:33:16 PM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Rev: $231,000 -89.4% | Assets $19,986,000 | EPS -$2.17 | |
| Onconova Therapeutics, Inc. (TRAW) | 3/11/2021 4:35:02 PM | View | Financials | Earnings | SEC | Y 2020 | Rev $57,000 +90.0% | Assets $19,986,000 | EPS -$0.52 | Export Earnings Model | |
| Onconova Therapeutics, Inc. (TRAW) | 1/14/2021 12:25:48 PM | View | Proxy | SEC | Y 2020 | ||||||
| Onconova Therapeutics, Inc. (TRAW) | 11/16/2020 4:33:32 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Rev: $66,000 +4.8% | Assets $25,207,000 | EPS -$0.52 | |
| Onconova Therapeutics, Inc. (TRAW) | 11/12/2020 4:17:28 PM | View | Financials | Earnings | SEC | 3Q 2020 | Rev $66,000 +4.8% | Assets $25,207,000 | EPS -$0.52 | Export Earnings Model | |
| Onconova Therapeutics, Inc. (TRAW) | 8/12/2020 5:25:22 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Rev: $56,000 -97.2% | Assets $28,199,000 | EPS -$0.65 | |
| Onconova Therapeutics, Inc. (TRAW) | 8/12/2020 4:14:18 PM | View | Financials | Earnings | SEC | 2Q 2020 | Rev $56,000 -97.2% | Assets $28,199,000 | EPS -$0.65 | Export Earnings Model | |
| Onconova Therapeutics, Inc. (TRAW) | 5/15/2020 4:30:38 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Rev: $52,000 -23.5% | Assets $32,073,000 | EPS -$0.03 | |
| Onconova Therapeutics, Inc. (TRAW) | 5/14/2020 4:33:01 PM | View | Financials | Earnings | SEC | 1Q 2020 | Rev $52,000 -23.5% | Assets $32,073,000 | EPS -$0.03 | Export Earnings Model | |
| Onconova Therapeutics, Inc. (TRAW) | 4/23/2020 4:31:26 PM | View | Proxy | SEC | Y 2019 | ||||||
| Onconova Therapeutics, Inc. (TRAW) | 3/27/2020 4:35:33 PM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Rev: $2,183,000 +77.8% | Assets $23,674,000 | EPS -$1.49 | |
| Onconova Therapeutics, Inc. (TRAW) | 3/24/2020 4:14:04 PM | View | Financials | Earnings | SEC | Y 2019 | Rev $30,000 -49.2% | Assets $23,674,000 | EPS $1.14 | Export Earnings Model | |
| Onconova Therapeutics, Inc. (TRAW) | 11/12/2019 5:31:03 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Rev: $63,000 -47.5% | Assets $6,005,000 | EPS -$0.75 | |
| Onconova Therapeutics, Inc. (TRAW) | 8/14/2019 5:35:47 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Rev: $2,022,000 +316.9% | Assets $8,580,000 | EPS -$0.60 | |
| Onconova Therapeutics, Inc. (TRAW) | 8/14/2019 7:55:37 AM | View | Financials | Earnings | SEC | 2Q 2019 | Rev $2,022,000 +316.9% | Assets $8,580,000 | EPS -$0.60 | Export Earnings Model | |
| Onconova Therapeutics, Inc. (TRAW) | 5/15/2019 5:20:43 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Rev: $68,000 -87.9% | Assets $11,341,000 | EPS -$1.29 | |
| Onconova Therapeutics, Inc. (TRAW) | 5/14/2019 8:16:57 AM | View | Financials | Earnings | SEC | 1Q 2019 | Rev $68,000 -87.9% | Assets $11,341,000 | EPS -$1.29 | Export Earnings Model | |
| Onconova Therapeutics, Inc. (TRAW) | 4/29/2019 4:50:12 PM | View | Proxy | SEC | Y 2018 | ||||||
| Onconova Therapeutics, Inc. (TRAW) | 4/1/2019 5:12:36 PM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Rev: $1,228,000 +56.0% | Assets $17,923,000 | EPS -$4.99 | |
| Onconova Therapeutics, Inc. (TRAW) | 3/26/2019 7:57:02 AM | View | Financials | Earnings | SEC | Y 2018 | Rev $59,000 -58.7% | Assets $17,923,000 | EPS -$0.85 | Export Earnings Model | |
| Onconova Therapeutics, Inc. (TRAW) | 11/14/2018 5:07:28 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Rev: $120,000 +9.1% | Assets $23,136,000 | EPS -$0.94 | |
| Onconova Therapeutics, Inc. (TRAW) | 11/13/2018 8:32:25 AM | View | Financials | Earnings | SEC | 3Q 2018 | Rev $120,000 +9.1% | Assets $23,136,000 | EPS -$0.94 | Export Earnings Model | |
| Onconova Therapeutics, Inc. (TRAW) | 8/14/2018 5:36:18 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Rev: $485,000 +49.7% | Assets $30,203,000 | EPS -$1.10 | |
| Onconova Therapeutics, Inc. (TRAW) | 8/14/2018 8:32:43 AM | View | Financials | Earnings | SEC | 2Q 2018 | Rev $485,000 +49.7% | Assets $30,203,000 | EPS -$1.10 | Export Earnings Model | |
| Onconova Therapeutics, Inc. (TRAW) | 6/8/2018 11:14:20 AM | View | Proxy | SEC | Y 2017 | ||||||
| Onconova Therapeutics, Inc. (TRAW) | 5/17/2018 5:24:41 PM | View | Proxy | SEC | Y 2017 | ||||||
| Onconova Therapeutics, Inc. (TRAW) | 5/15/2018 4:55:13 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Rev: $564,000 +168.6% | Assets $8,615,000 | EPS -$5.04 | |
| Onconova Therapeutics, Inc. (TRAW) | 5/15/2018 9:02:38 AM | View | Financials | Earnings | SEC | 1Q 2018 | Rev $564,000 +168.6% | Assets $8,615,000 | EPS -$5.04 | Export Earnings Model | |
| Onconova Therapeutics, Inc. (TRAW) | 3/16/2018 5:07:00 PM | Micro | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Rev: $787,000 -85.8% | Assets $4,979,000 | EPS -$40.15 | |
| Onconova Therapeutics, Inc. (TRAW) | 3/8/2018 8:44:17 AM | View | Financials | Earnings | SEC | Y 2017 | Rev $143,000 -17.3% | Assets $4,979,000 | EPS -$8.78 | Export Earnings Model | |
| Onconova Therapeutics, Inc. (TRAW) | 2/28/2018 8:03:37 AM | View | Proxy | SEC | Y 2017 | ||||||
| Onconova Therapeutics, Inc. (TRAW) | 11/9/2017 9:07:10 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Rev: $110,000 -93.3% | Assets $8,802,000 | EPS -$10.60 | |
| Onconova Therapeutics, Inc. (TRAW) | 11/9/2017 8:56:18 AM | View | Financials | Earnings | SEC | 3Q 2017 | Rev $110,000 -93.3% | Assets $8,802,000 | EPS -$10.60 | Export Earnings Model | |
| Onconova Therapeutics, Inc. (TRAW) | 8/15/2017 7:45:20 AM | View | Financials | Earnings | SEC | 2Q 2017 | Rev $324,000 -85.6% | Assets $16,100,000 | EPS -$0.29 | Export Earnings Model | |
| Onconova Therapeutics, Inc. (TRAW) | 8/14/2017 5:15:52 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Rev: $324,000 -85.6% | Assets $16,100,000 | EPS -$0.29 | |
| Onconova Therapeutics, Inc. (TRAW) | 5/15/2017 5:12:51 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Rev: $210,000 -85.8% | Assets $16,554,000 | EPS -$1.23 | |
| Onconova Therapeutics, Inc. (TRAW) | 5/15/2017 8:45:40 AM | View | Financials | Earnings | SEC | 1Q 2017 | Rev $210,000 -85.8% | Assets $16,554,000 | EPS -$1.23 | Export Earnings Model | |
| Onconova Therapeutics, Inc. (TRAW) | 4/12/2017 4:05:29 PM | View | Proxy | SEC | Y 2016 | ||||||
| Onconova Therapeutics, Inc. (TRAW) | 3/29/2017 5:17:28 PM | Micro | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Rev: $5,546,000 -51.6% | Assets $23,233,000 | EPS -$4.44 | |
| Onconova Therapeutics, Inc. (TRAW) | 3/27/2017 8:50:22 AM | View | Financials | Earnings | SEC | Y 2016 | Rev $173,000 -98.2% | Assets $23,233,000 | EPS -$0.54 | Export Earnings Model | |
| Onconova Therapeutics, Inc. (TRAW) | 11/14/2016 5:30:32 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Rev: $1,651,000 +1.8% | Assets $28,088,000 | EPS -$0.29 | |
| Onconova Therapeutics, Inc. (TRAW) | 11/14/2016 3:02:57 PM | View | Financials | Earnings | SEC | 3Q 2016 | Rev $1,651,000 +1.8% | Assets $28,088,000 | EPS -$0.29 | Export Earnings Model | |
| Onconova Therapeutics, Inc. (TRAW) | 8/15/2016 4:31:53 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2016 ending: 6/30/2016 | Rev: $2,248,000 +1,727.6% | Assets $16,202,000 | EPS -$1.96 | |
| Onconova Therapeutics, Inc. (TRAW) | 8/15/2016 9:02:03 AM | View | Financials | Earnings | SEC | 2Q 2016 | Rev $2,248,000 +1,727.6% | Assets $16,202,000 | EPS -$1.96 | Export Earnings Model | |
| Onconova Therapeutics, Inc. (TRAW) | 5/11/2016 4:56:26 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2016 ending: 3/31/2016 | Rev: $1,474,000 +1,193.0% | Assets $19,642,000 | EPS -$2.65 | |
| Onconova Therapeutics, Inc. (TRAW) | 5/11/2016 4:11:13 PM | View | Financials | Earnings | SEC | 1Q 2016 | Rev $1,474,000 +1,193.0% | Assets $19,642,000 | EPS -$2.65 | Export Earnings Model | |
| Onconova Therapeutics, Inc. (TRAW) | 4/13/2016 4:15:27 PM | View | Proxy | SEC | Y 2015 | ||||||
| Onconova Therapeutics, Inc. (TRAW) | 3/28/2016 8:32:47 AM | Micro | View | Financials | 10-K | SEC | Y 2015 ending: 12/31/2015 | Rev: $11,456,000 +1,332.0% | Assets $23,445,000 | EPS -$10.54 | |
| Onconova Therapeutics, Inc. (TRAW) | 3/28/2016 8:30:18 AM | View | Financials | Earnings | SEC | Y 2015 | Rev $9,597,000 +8,318.4% | Assets $23,445,000 | EPS $1.81 | Export Earnings Model | |
| Onconova Therapeutics, Inc. (TRAW) | 11/12/2015 4:02:02 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2015 ending: 9/30/2015 | Rev: $1,622,000 +1,322.8% | Assets $25,969,000 | EPS -$2.60 | |
| Onconova Therapeutics, Inc. (TRAW) | 11/12/2015 8:45:16 AM | View | Financials | Earnings | SEC | 3Q 2015 | Rev $1,622,000 +1,322.8% | Assets $25,969,000 | EPS -$2.60 | Export Earnings Model | |
| Onconova Therapeutics, Inc. (TRAW) | 8/13/2015 8:36:58 AM | View | Financials | Earnings | SEC | 2Q 2015 | Rev $123,000 -1.6% | Assets $27,737,000 | EPS -$4.13 | Export Earnings Model | |
| Onconova Therapeutics, Inc. (TRAW) | 8/13/2015 8:35:50 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2015 ending: 6/30/2015 | Rev: $123,000 -1.6% | Assets $27,737,000 | EPS -$4.13 | |
| Onconova Therapeutics, Inc. (TRAW) | 7/8/2015 4:06:08 PM | View | Financials | Earnings | SEC | 2Q 2015 | Rev $123,000 -1.6% | Assets $27,737,000 | EPS -$4.13 | Export Earnings Model | |
| Onconova Therapeutics, Inc. (TRAW) | 5/15/2015 4:06:39 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2015 ending: 3/31/2015 | Rev: $114,000 -74.5% | Assets $36,713,000 | EPS -$0.57 | |
| Onconova Therapeutics, Inc. (TRAW) | 5/14/2015 4:05:16 PM | View | Financials | Earnings | SEC | 1Q 2015 | Rev $114,000 -74.5% | Assets $36,713,000 | EPS -$0.57 | Export Earnings Model | |
| Onconova Therapeutics, Inc. (TRAW) | 4/29/2015 11:40:19 AM | View | Proxy | SEC | Y 2014 | ||||||
| Onconova Therapeutics, Inc. (TRAW) | 3/30/2015 5:02:25 PM | Micro | View | Financials | 10-K | SEC | Y 2014 ending: 12/31/2014 | Rev: $800,000 -83.2% | Assets $47,337,000 | EPS -$2.94 | |
| Onconova Therapeutics, Inc. (TRAW) | 3/27/2015 7:56:08 AM | View | Financials | Earnings | SEC | Y 2014 | Rev $114,000 -94.1% | Assets $47,337,000 | EPS -$0.62 | Export Earnings Model | |
| Onconova Therapeutics, Inc. (TRAW) | 11/14/2014 4:06:17 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2014 ending: 9/30/2014 | Rev: $114,000 -89.8% | Assets $62,274,000 | EPS -$0.69 | |
| Onconova Therapeutics, Inc. (TRAW) | 11/13/2014 4:05:41 PM | View | Financials | Earnings | SEC | 3Q 2014 | Rev $114,000 -89.8% | Assets $62,274,000 | EPS -$0.69 | Export Earnings Model | |
| Onconova Therapeutics, Inc. (TRAW) | 8/14/2014 4:31:15 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2014 ending: 6/30/2014 | Rev: $125,000 -78.8% | Assets $74,573,000 | EPS -$0.77 | |
| Onconova Therapeutics, Inc. (TRAW) | 8/13/2014 4:15:57 PM | View | Financials | Earnings | SEC | 2Q 2014 | Rev $125,000 -78.8% | Assets $74,573,000 | EPS -$0.77 | Export Earnings Model | |
| Onconova Therapeutics, Inc. (TRAW) | 5/15/2014 4:02:17 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2014 ending: 3/31/2014 | Rev: $447,000 -59.9% | Assets $89,718,000 | EPS -$0.87 | |
| Onconova Therapeutics, Inc. (TRAW) | 5/15/2014 10:48:45 AM | View | Financials | Earnings | SEC | 1Q 2014 | Rev $447,000 -59.9% | Assets $89,718,000 | EPS -$0.87 | Export Earnings Model | |
| Onconova Therapeutics, Inc. (TRAW) | 4/29/2014 8:29:35 AM | View | Proxy | SEC | Y 2013 | ||||||
| Onconova Therapeutics, Inc. (TRAW) | 3/20/2014 4:24:00 PM | Micro | View | Financials | 10-K | SEC | Y 2013 ending: 12/31/2013 | Rev: $4,753,000 -89.7% | Assets $105,153,000 | EPS -$6.12 | |
| Onconova Therapeutics, Inc. (TRAW) | 3/10/2014 5:18:17 PM | View | Financials | Earnings | SEC | Y 2013 | Rev $1,930,000 -35.0% | Assets $105,153,000 | EPS -$0.68 | Export Earnings Model | |
| Onconova Therapeutics, Inc. (TRAW) | 11/14/2013 3:13:26 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2013 ending: 9/30/2013 | Rev: $1,116,000 -97.4% | Assets $122,717,000 | EPS -$1.34 | |
| Onconova Therapeutics, Inc. (TRAW) | 11/12/2013 5:18:54 PM | View | Financials | Earnings | SEC | 3Q 2013 | Rev $1,116,000 -97.4% | Assets $122,717,000 | EPS -$1.34 | Export Earnings Model | |
| Onconova Therapeutics, Inc. (TRAW) | 9/6/2013 4:49:39 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2013 ending: 6/30/2013 | Rev: $591,000 +168.6% | Assets $57,914,000 | EPS -$5.21 | |
| Onconova Therapeutics, Inc. (TRAW) | 9/6/2013 2:53:13 PM | View | Financials | Earnings | SEC | 2Q 2013 | Rev $591,000 +168.6% | Assets $57,914,000 | EPS -$5.21 | Export Earnings Model |